SPRY (STOCKS)
ARS Pharmaceuticals, Inc. Common Stock
$8.000000
-0.050000 (-0.62%)
Prev close: $8.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard E. Lowenthal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $794.38M
- Employees
- 167
- P/E (TTM)
- -4.63
- P/B (TTM)
- 7.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $84.28M |
| Benefits Costs and Expenses | $255.66M |
| Costs And Expenses | $255.66M |
| Operating Expenses | $263.73M |
| Selling, General, and Administrative Expenses | $230.12M |
| Depreciation and Amortization | $1.37M |
| Research and Development | $13.18M |
| Other Operating Expenses | $19.06M |
| Operating Income/Loss | -$179.45M |
| Income/Loss From Continuing Operations After Tax | -$171.30M |
| Income/Loss From Continuing Operations Before Tax | -$171.38M |
| Income Tax Expense/Benefit | -$80.00K |
| Income Tax Expense/Benefit, Current | -$80.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$171.30M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$171.30M |
| Net Income/Loss Available To Common Stockholders, Basic | -$171.30M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.74 |
| Diluted Earnings Per Share | -$1.74 |
| Basic Average Shares | 98,566,481 |
| Diluted Average Shares | 98,566,481 |
| Assets | $327.65M |
| Current Assets | $284.90M |
| Inventory | $31.42M |
| Other Current Assets | $253.47M |
| Noncurrent Assets | $42.76M |
| Fixed Assets | $2.47M |
| Intangible Assets | $14.45M |
| Other Non-current Assets | $25.84M |
| Liabilities | $213.39M |
| Current Liabilities | $39.15M |
| Accounts Payable | $5.73M |
| Other Current Liabilities | $33.42M |
| Noncurrent Liabilities | $174.25M |
| Long-term Debt | $96.37M |
| Other Non-current Liabilities | $77.88M |
| Equity | $114.26M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $114.26M |
| Liabilities And Equity | $327.65M |
| Net Cash Flow From Operating Activities | -$170.87M |
| Net Cash Flow From Operating Activities, Continuing | -$170.87M |
| Net Cash Flow From Investing Activities | $56.77M |
| Net Cash Flow From Investing Activities, Continuing | $56.77M |
| Net Cash Flow From Financing Activities | $104.60M |
| Net Cash Flow From Financing Activities, Continuing | $104.60M |
| Net Cash Flow | -$9.50M |
| Net Cash Flow, Continuing | -$9.50M |
| Comprehensive Income/Loss | -$171.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$171.39M |
| Other Comprehensive Income/Loss | -$171.39M |